Third Quarter Results Presentation
Filed with ASX · · 44 pages · English
This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forwa
In the deck
Story so far
Earlier from Mesoblast
- MSB Q3 Financial Results and Operational Highlights
- S&P DJI Announces March 2022 Quarterly Rebalance
- Second Quarter Results Presentation
- Ulcerative Colitis & Crohns Results Presented at ECCO
- Appendix 4C Quarterly Activity Report
Later from Mesoblast
- Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
- Reinstatement to Quotation
- US$45 Million Private Placement to Major Shareholders
- Preliminary Final Report
- MSB Annual Financial Results and Operational Highlights
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast